Neurohormonal Activation After Atrial Fibrillation Initiation in Patients Eligible for Catheter Ablation: A Randomized Controlled Study

Author:

Charitakis Emmanouil1,Walfridsson Håkan1,Nylander Eva2,Alehagen Urban1

Affiliation:

1. Department of Cardiology and Department of Medical and Health Sciences, Linköping University, Linköping, Sweden

2. Department of Clinical Physiology and Department of Medical and Health Sciences, Linköping University, Linköping, Sweden

Abstract

Background Biomarker activation in atrial fibrillation ( AF ) has been widely studied, but the immediate effect of AF initiation remains unclear. We studied the effect of AF initiation on 2 cardiac biomarkers: the N‐terminal fragment of the proB‐type natriuretic peptide ( NT ‐pro BNP ), the midregional fragment of the N‐terminal of pro‐atrial natriuretic peptide ( MR ‐pro ANP ), and 2 extracardiac biomarkers—the copeptin and the midregional portion of proadrenomedullin ( MR ‐pro ADM ). Methods and Results This was a randomized controlled study, including 45 patients with AF who had been referred for radiofrequency ablation to the University Hospital, Linköping, Sweden, between February 2012 and April 2014. Freedom from AF during the 4 days prior to radiofrequency ablation was confirmed by transtelephonic ECG s. Biomarkers were collected from the femoral vein (fv), coronary sinus ( CS ), and left atrium ( LA ) prior to AF initiation (baseline) and 30 minutes later. The MR ‐pro ANP and NT ‐pro BNP concentrations increased in the intervention group compared with the control group 30 minutes after the initiation of AF ( MR ‐pro ANP : P fv <0.001, P CS <0.001, P LA <0.001; NT ‐pro BNP : P LA <0.001). Copeptin levels in patients without ischemic heart disease were decreased after the initiation of AF ( P fv =0.003, P CS =0.015, P LA =0.011). Conclusions AF is a strong stimulus that results in immediate activation of different biomarkers. Clinical Trial Registration URL : http://www.clinicaltrials.gov . Unique identifier: NCT 01553045.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3